
Focusing on issues such as sustainable medicine, prevention and treatment of myopia in children, cardiovascular care, and generative AI
AI-generated summary
The Affiliated Hospital of National Yang-Ming University of Science and Technology celebrates its 130th anniversary, and a series of celebration activities have been launched since the 4th. Jiaotong University was founded in 1896 and Yilan Hospital was established in the same year. This year is the fifth year of the joint school.
The Hospital Affiliated to National Yang-Ming Chiao Tung University celebrated its 130th anniversary and today joined hands with National Yilan University to host the 16th International Medical Symposium. (Photo by reporter Wang Junqi)
[Reporter Wang Junqi/Report from Yilan] The Affiliated Hospital of National Yang-Ming Chiao Tung University celebrates its 130th anniversary. Today (7), it joins hands with National University of Yilan to host the 16th International Medical Symposium, focusing on topics such as sustainable medical care, childhood myopia prevention and treatment, cardiovascular care, and generative AI. A series of hospital celebration activities have been launched in full swing since the 4th, showing that the century-old hospital is in line with the vision of future smart medical care and planning a smart and healthy Yilan with "no walls"!
Huang Zhixian, Director of the Hospital Affiliated to Yangming Jiaotong University, said that four generations of his family have served here. Old photos are the living history of the hospital. Yilan’s population of more than 400,000 is a microcosm of Taiwan. It is a very good community model. With the support of Yangming Jiaotong University’s abundant resources, we will make every effort to implement teaching and research. We hope to build "Healthy Yilan" into a cutting-edge and model nationwide on the basis of 130 years of solid foundation.
Lin Qihong, President of Yangtze River Jiaotong University, said that this year (2026) is the fifth year of joint schooling. Coincidentally, Jiaotong University was founded in 1896 and Yilan Hospital was established in the same year, which is a rare connection in 130 years. Yilan is a very suitable place to establish a medical model. The school will work with the hospital to deeply explore the integration of community and hospital-based medical care to create a future service model.
This seminar mainly discusses the shift of medical care from treatment to prevention. Luo Yijun, director of the Department of Disease Control and Prevention of the Ministry of Health and Welfare, shared Taiwan's 40 years of experience in epidemic prevention and control from response to prevention; Professor Katsuhisa Kojima of Josai International University in Japan analyzed the impact of population aging. Former Minister of Health and Welfare Qiu Wenta talked about the concept of "hospital without walls" and outlined a vision for medical care to be deeply embedded in families and communities.
The Affiliated Hospital of Yangtze River University said that in terms of local practice, the hospital has been deeply involved in children's vision protection for many years, promoting "Everyday Outdoor 120" and early intervention, which has reduced the myopia rate among Yilan's large-scale children from 15.4% to about 8%. The team has also actively promoted early-stage myopia prevention and piloted the "Natural Landscape Classroom" to create a learning environment for children to protect their eyesight and implement preventive medicine.
Cardiovascular care has been honed over the past 20 years. The Affiliated Hospital of Yangtze River University has successfully built a medical center-level system, taking the lead in introducing cutting-edge technologies such as pulsed field ablation, transcatheter aortic valve replacement, and 3T cardiac magnetic resonance imaging, which has greatly strengthened Yilan's emergency and critical care capacity. It not only saves people from traveling across regions for medical treatment, but also firmly establishes a century-old medical guardianship.
At the International Medical Seminar organized by the Affiliated Hospital of Yangming Jiaotong University, Dean Huang Zhixian (4th from left) takes a group photo with Director of Disease Control and Prevention Luo Yijun (4th from right) and others. (Photo by reporter Wang Junqi)

The Taichung Veterans Affairs Center broke ground on the construction of a medical science and technology building at a cost of 4.082 billion yuan. Executive Director Zhuo Rongtai attended and said that our country's health insurance has been recognized internationally, and the government's medical and health insurance budget has increased year by year, exceeding one trillion yuan. The building is expected to be completed in November 2029 and opened in April 2030. It will have core facilities such as an international conference center and an artificial intelligence research center.

There is one new imported case of dengue fever in Tainan. The case is a Chinese female in her 40s from Yongkang District. She developed symptoms 4 days after returning from a trip to Vietnam as an employee and was diagnosed at Annan Hospital. She is the 17th imported case in Tainan this year. The disease management unit has launched emergency spray prevention and control, environmental breeding source removal and vector mosquito density surveys for his residence. As of November 6, there have been a total of 238 cases in the country, including 221 imported cases. Vietnam has the largest number of infected countries.

Salary data of Changhua Christian Medical Center has been exposed. The average monthly salary of thoracic surgeons is 1.577 million yuan, setting a new ceiling in the industry; cardiac surgery is 1.439 million yuan, anesthesiology is 609,000 yuan, and dermatology is 324,000 yuan. Chief Dean Chen Mukuan pointed out that openness and transparency in procurement negotiations and saving operating costs to reward employees are the keys to supporting high salaries and low out-of-pocket medical expenses.

A research team from Brigham Young University in the United States used nanogene engineering to modify macrophages and reduced solid tumors by 46% in mouse experiments. In in vitro tests, 90% of lung cancer cells were eliminated within 24 hours. The technology has been patented and licensed to biotechnology companies, but it is still in the pre-clinical development stage and has not yet been subjected to human clinical trials, and the relevant results have not been published in peer-reviewed journals.

The FDA is investigating a risk of neoplasia, including malignancy, associated with Novartis' gene therapy Zolgensma. The Swiss drugmaker disclosed two cases of tumors in children linked to the therapy and reported nine tumor cases overall among patients treated since its 2019 approval.

The U.S. Prodose Pharma painkillers were recalled due to label discrepancies, and the Assam plant of India's Sun Pharmaceuticals stopped production and recalled eye drops due to quality defects. The Food and Drug Administration verified that neither drug license nor project input record was approved by my country.